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SHORT COMMUNICATION
Cytotoxin from polymorphonuclear leukocytes and inflammatory ascitic
fluids
M. Yamazaki, M. Ikenami & T. Sugiyama
Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko-cho, Tsukui-gun, Kanagawa 199-01, Japan.
Previously, we reported that polymorphonuclear leukocytes
(PMNs) from the peritoneal cavity of mice could kill murine
tumour cells in vitro on addition of appropriate mediators
such as plant lectins (Ikenami & Yamazaki, 1983; Tsunawaki
et al., 1983), animal lectins (Yamazaki et al., 1983),
antitumour antibody (Tsunawaki et al., 1983), anticancer
chemotherapeutic drugs (Ikenami et al., 1985) and im-
munomodulators (Morikawa et al., 1985b). Purified PMNs
(99.1-99.5%) also showed cytolytic activity (Ikenami &
Yamazaki, 1985). Some non-protein factor such as hydrogen
peroxide produced by PMNs is involved in the lytic process
with immunomo-dulators (Morikawa et al., 1985a) and
preliminary studies showed that a protein factor from PMNs
participated in other types of killing (Ikenami & Yamazaki,
1985); in other words, a PMN-derived factor can lyse
tumour cells in co-operation with wheat germ agglutinin or
actinomycin D. In this work, we investigated the character
of a PMN-derived cytotoxin. This paper reports that not
only macrophages, but also inflammatory PMNs can
produce a cytotoxin and that PMNs may produce this
cytotoxin in vivo.
Inbred male C3H/He and DDY mice were obtained from
Shizuoka Experimental Animal Farm (Shizuoka, Japan).
Polymorphonuclear leukocytes (PMNs) were prepared as
described previously (Ikenami & Yamazaki, 1985). Briefly,
2ml of 12% casein solution was injected into the peritoneal
cavity of mice and the peritoneal exudate was harvested 6h
later, passed through nylon mesh and centrifuged at 300g
for 5min. The cells were washed twice with RPMI-1640
medium (Nissui Seiyaku Co., Tokyo) supplemented with
100 Uml-1 of penicillin (Banyu Pharmaceutical Co., Tokyo)
and 100 gml-P of streptomycin (Meiji Seika Co., Tokyo).
Usually, the peritoneal cells were suspended in RPMI-1640
medium containing 5% heat-inactivated foetal calf serum
(Gibco, Grand Island, NY; called medium hereafter). The
media utilised contained <20pgml-1 lipopolysaccharide
(LPS) Samples were stained with Giemsa stain for morpho-
logical examination. These peritoneal cells, 93-98% of which
were polymorphonuclear leukocytes, were used as the poly-
morphonuclear leukocyte preparation. Peritoneal
macrophages were obtained 4 days after i.p. injection of
lOO1 g heat-killing BCG or 2ml of 12% casein solution into
C3H/He mice. These cells were adhered to plastic
microplates and the adherent cells were vigorously washed
three times with warm phosphate-buffered saline. More than
95% of these adherent cells were macrophages, as
determined by Giemsa staining and measurement of uptake
of carbon particles.
Cytolysis of L929 cells was measured by the method of
Ruff & Gifford (1980). Briefly, L929 cells (8 x 104cells) were
mixed with test samples and 1 Mgml-1 of actinomycin D
(Sigma Chemical Co., St Louis, MO) in the wells (7mm
diameter) of flat-bottomed microplates, and incubated in a
CO2 incubator for 18h. Then the medium was removed and
residual cells were stained with crystal violet for 15min.
After addition of 0.1 ml of sodium dodecyl sulphate (0.5%),
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the absorbance of the supernatant at 590nm was measured
in a photometer (Myreader 7, Sanko Junyaku Co., Tokyo).
Cytolytic activity was calculated as follows:
cytolysis (%) 1_experimental absorbance
control absorbance
The dilution of the sample giving the half survival ratio
(ED50) was obtained from a dose-response curve. Cytolytic
activity (units) was calculated as the ratio of the ED50 of the
culture supernatant to that of rabbit tumour necrosis serum
(Abe et al., 1985) in each test plate. The cytolytic activity of
this rabbit tumour necrosis serum was equivalent to 6 x 103
units of recombinant human TNF.
We reported previously that direct contact between
effector PMNs and target tumour cells is not essential for
tumour lysis and that lysis involves a protein factor from the
PMNs (Ikenami & Yamazaki, 1985). Since the protein factor
alone was not cytolytic to tumour cells, the cytolysis seemed
to be induced by a combination of a factor from the PMNs
and actinomycin D, and the PMNs seemed to release this
factor spontaneously into the medium.
Lipopolysaccharide (LPS) stimulates the release of
cytolytic factors such as tumour necrosis factor (TNF) from
macrophages. Therefore, we examined whether LPS
enhanced the release of cytotoxin from PMNs. Table I
shows that LPS augmented the release of cytotoxin from
macrophages, but not from PMNs. These results suggest that
casein-induced peripheral PMNs are fully activated for cyto-
toxin release without any additional stimulation, and that
the mechanisms of cytotoxin release from macrophages and
PMNs may be different.
The culture supernatants of PMNs and macrophages were
subjected to high performance liquid chromatography
(HPLC) to estimate the molecular weights of the cytotoxins.
The cytotoxin from PMNs was mainly eluted in the fraction
corresponding to a molecular weight of about 70kDa with a
shoulder of material of about 50kDa (Figure la). The
cytotoxin released from BCG-induced macrophages was
eluted in the fraction of about 50kDa (Figure lb). Thus the
cytotoxins from PMNs and macrophages differ in molecular
weight.
PMNs accumulate at the site of inflammation, so, to
determine whether the cytotoxin was detectable in vivo, we
examined the cytotoxic activity of inflammatory ascitic fluid.
PMNs accumulate at the site of injection of casein or fl-1-3-
D-glucan from Alcaligenes faecalis (Morikawa et al., 1984).
As shown in Figure 2, ascitic fluid obtained from the
peritoneal cavity after infiltration of PMNs showed cytotoxic
activity even at a concentration of 1%. Cytotoxic activity in
the ascitic fluid appeared 3-6h after casein injection with
accumulation of PMNs and then gradually disappeared with
time (data not shown).
On HPLC, the cytotoxin from inflammatory ascites was
mainly eluted in the fraction of about 70 kDa with a
shoulder of about 50kDa (Figure lc) like the cytotoxin from
PMNs (Figure la). These data suggest that the cytotoxin
may be released from PMNs into the inflammatory ascites in
vivo.
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Table I Effect of LPS on release of cytotoxin from phagocytes
Cytotoxin(Uml1)' Enhancement
Phagocytes -LPS +LPS (+LPS/- LPS)
PMNs (casein-induced) 5.9 5.4 0.9
Macrophages (casein-induced) 1.9 7.4 3.9
Macrophages (BCG-induced) 19.4 82.8 4.3
aSupernatants (5ml) were obtained after culture of PMNs (2 x 107ml-1)
or macrophages (5 x 106 cellsml-) with or without LPS (0.1 jgml -') for
5h. Cytolysis of L929 cells was measured in the presence of 1 jgml of
actinomycin D.
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Figure 1 HPLC profiles of cytotoxin in supernatants from 5h
cultures of PMNs (a) and macrophages incubated with LPS (b).
The concentrated supernatants and cell-free ascites (c) were
subjected to HPLC (Shimadzu, LC-6A) on a 0.75 x 60cm column
of G3000SW (Toyo Soda Manufacturing Co.). Arrows indicate
molecular weights of standards.
Most previous studies on the cytotoxicity of PMNs have
been focused on oxygen metabolites. PMNs have been
shown to kill tumour cells through oxygen-dependent
pathways (Clark & Klevanoff, 1979; Dallegri et al., 1983;
Nathan et al., 1979). We also reported that hydrogen
peroxide was an effector molecule in immunomodulator-
dependent PMN-mediated tumour lysis (Morikawa et al.,
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Figure 2 Cytolytic activities of inflammatory ascitic fluids. Cell-
free ascites obtained 6h after injection of 2ml of 12% caseinate
(A) or lOO,ug of,, 1-3-D-glucan (0) were used for cytolytic
assay. Bars indicate s.d.
1985a). However, the present PMN factor was not an
oxygen metabolite such as hydrogen peroxide; it seemed to
be a protein, because it was heat-labile and was inactivated
by trypsin (Ikenami & Yamazaki, 1985).
This spontaneously relased cytotoxin was antigenically
indistinguishable from TNF from macrophages (data not
shown), so it may be a TNF-like molecule or TNF itself.
However, its release from PMNs was not stimulated by LPS
(Table I), which enhances release of TNF from
macrophages, and its molecular weight was different from
that of TNF from macrophages (Figure 1).
This TNF-like cytotoxin was present in inflammatory
ascites in vivo as well as being relased spontaneously in vitro
(Figures 1 and 2). Inflammatory PMNs probably contain a
TNF-like cytotoxin and release it locally in vivo, since recent
studies (Beuther & Cerami, 1986; Old, 1987) have indicated
that TNF is an endogenous mediator of inflammation. In
fact, TNF has been reported to induce chemotaxis (Ming et
al., 1987) and production of oxygen metabolites (Klevanoff
et al., 1986) by phagocytes.
Recently, TNF has been found in leukocytes (Cuturi et al.,
1987), NK cells (Degliantoni et al., 1985) and fibroblasts
(Rubin et al., 1986). We also found that bone marrow cells
released a TNF-like cytotoxin (Okutomi et al., 1987).
Therefore, TNF is not a specific product of monocytes/
macrophages. PMNs are phagocytic and inflammatory cells,
and can produce interleukin-l (Yoshinaga et al., 1985),
oxygen metabolites (Clark & Klevanoff, 1979) and platelet
activating factor (Lother et al., 1980) just like macrophages.
These characteristics indicate that PMNs are basically similar
to macrophages. Thus PMNs can probably also produce
TNF or a TNF-like cytotoxin and we conclude that
inflammatory PMNs may produce cytotoxin in vivo.
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